YOU ARE HERE : Endocrinology and Diabetes / : outreach staff: Morris Foster - Director of Outreach
top
Section Home
Personnel
  A-Z list, faculty & staff
  Faculty
  Adjunct Faculty
  Clinical Fellows
  Clinical Staff
  Research Fellows / Post Docs
  Research Staff
  Graduate Students
  Outreach Staff
  Administrative Staff
  Endocrinology Event Calendar
Programs
  Clinical Fellowship Program
  Research Programs
  Weekly Seminars
  Annual Meetings
Research
  Program Grants
Diabetes Center
Oklahoma Diabetes Center
  N.Y.P.D. Kids
General Clinical Research Center
Visit Oklahoma City
Visit Tulsa
Links
bottom
Morris Foster, PhD
Director of Outreach
line

Mailing Address:
455 W. Lindsey, Rm. 505C
Norman, OK 73019

Telephone: 405-325-2491

Fax: 405-325-7386
Email: morris-foster@ouhsc.edu  

line

Professional Interests

  1. Community-based research
  2. Health disparities research
  3. Resesarch ethics

line

Education

1988 PhD - Anthropology - Yale University
1984 MPhil - Anthropology - Yale University
1981 BA - Anthroplogy - University of Oklahoma




Publications

Foster MW, Mulvihill JJ, Sharp RR. In Press. Evaluating the utility of personal genomic information. Genomics in Medicine.

Carabin, H, Keesee MS, Machado LJ, Brittingham T, Williams L, Sonleitner NK, Anderson KG, Cajina A, Foster MW. 2008. Estimation of the Prevalence of AIDS, Opportunistic Infections, and Standard of Care among Patients with HIV/AIDSReceiving Care Along the U.S.-Mexico Border through the Special Projects of National Significance: A Cross-Sectional Study. AIDS Patient Care and STDs Volume 22, Number 11.

Foster MW, Sharp RR. 2008. The contractual genome: how direct-to-consumer genomic services may help patients take ownership of their DNA. Personalized Medicine. 5(4): 399-404.

Foster MW, Sharp RR. 2008. Research with identifiable and targeted communities. In Oxford Textbook of Clinical Research Ethics, E. Emmanuel, et al. (Eds.). Oxford University Press.

Foster MW, Butler J. 2008. Cancer, HIV, and terrorism: translating public health models for disease prevention to terrorism and counter-terrorism. Critical Studies on Terrorism 1(1):  81-94.

International HapMap Consortium. 2007. Genome-wide detection and characterization of positive selection in human populations. Nature 449(7164):913-8.

International HapMap Consortium. 2007. A second generation human haplotype map of over 3.1 million SNPs. Nature 449(7164):851-61.

Foster MW, Sharp RR. 2007. Share and share alike: deciding how to distribute the scientific and social benefits of genomic data. Nature Reviews Genetics 8 (8): 633-38.

Sharp RR, Foster MW. 2007. Grappling with groups: protecting collective interests in biomedical research. Journal of Medicine and Philosophy 32 (4): 321-337.

Butler JW, Mumford, MD, Foster MW. 2006. A new paradigm for understanding conflicts of interest in clinical trials. In Philosophy and Ethics: New Research. Edited by Laura V. Siegal. New York: Nova Science Publishers. 

Keesee M, Shinault KA, Carabin H, Saleem AG, Anderson KG, Brittingham T, Williams L, Sonleitner NK, Cajina A, Schulhof R, Curiel H, Foster MW, and the US-Mexico Border HIV/AIDS Collaborative. 2006. A study of socio-demographic characteristics of HIV/AIDS individuals living and receiving care along the U.S.-Mexico Border through five SPNS demonstration projects. Journal of HIV/AIDS and Social Services 5 (2).

Foster MW. 2006. Analyzing the use of race and ethnicity in biomedical research from a local community perspective. Journal of Law, Medicine, and Ethics 34 (3), 508-512.

Foster MW, Sharp RR. 2006. Ethical issues in medical sequencing research: implications of genotype-phenotype studies for individuals and populations. Human Molecular Genetics 15:R45-R49.

Foster MW, Mulvihill JJ, Sharp RR. 2006. Investments in cancer genomics: who benefits and who decides? American Journal of Public Health 96 (11): 1960-1964.

Foster MW, Royal CDM, Sharp RR. 2006. The routinization of genetics and genomics: implications for ethical practices. Journal of Medical Ethics 32 (11): 635-638.

International HapMap Consortium. 2005. A haplotype map of the human genome. Nature 437:1299-1320.

Foster MW, Sharp RR. 2005. Will investments in large-scale prospective cohorts and biobanks limit our ability to discover weaker, less common genetic and environmental contributors to complex diseases? Environmental Health Perspectives 113: 119-122.

Foster MW, Sharp RR. 2005. Will investments in biobanks, prospective cohorts, and markers of common patterns of variation benefit other populations for drug response and disease susceptibility gene discovery? The Pharmacogenomics Journal 5: 75-80.

Foster MW, Sharp RR. 2004.Beyond race: towards a whole genome perspective on human populations and genetic variation. Nature Reviews Genetics 5 (10): 790-796.

International HapMap Consortium (Foster MW corresponding author) 2004. Integrating ethics and science in the International HapMap Project. Nature Reviews Genetics 5(6): 467-475.

Wang N, Zhou X, Tan FK, Foster MW, Arnett FC, Chakraborty R. 2004. Genetic signatures of pre-expansion bottleneck in the Choctaw population of Oklahoma. American Journal of Physical Anthropology 124: 373-379.

Foster MW, Sharp RR. 2004. Genetic research with minority populations. In Race and Research in Focus: Perspectives of Minority Participation in Health Research, Bettina M. Beech and Maurine Goodman (editors), American Public Health Association Monograph Series.

Foster MW. 2003. Human Genome Diversity Project in North America. In Encyclopedia of the Human Genome. Nature Publishing.

International HapMap Consortium (Bentley DR, Foster MW corresponding authors) 2003. The International HapMap Project. Nature 426: 789-796.

Foster MW. 2003. Pharmacogenomics and the social construction of identity. In Pharmacogenomics and Pharmacy Practice in Pharmacogenomics: Social, Ethical and Clinical Dimensions. Mark A. Rothstein (ed. ); New York: John Wiley & Sons, Inc.

Foster MW, Aston CE. 2003. A practice approach for identifying previously unsuspected environmental contributors to SLE and other complex diseases. Environmental Health Perspectives 111(4): 593-597.

Foster MW, Sharp RR. Jun 2002. Race, ethnicity, and genomics: social classifications as proxies of biological heterogeneity. Genome Research. 12:844-50. 

Sharp RR, Foster MW. 2002. An analysis of research guidelines on the collection and use of human biological materials from American Indian and Alaskan Native communities. Jurimetrics. 42:165-186. 

Sharp RR, Foster MW. 2002. Community involvement in the ethical review of genetic research: lessons from American Indian and Alaska Native populations. Environmental Health Perspectives. 110:145-148. 

Foster MW, Sharp RR, Mulvihill JJ. Jun 2001. Pharmacogenetics, race, and ethnicity: social identities and      individualized medical care. Therapeutic Drug Monitoring. 23:232-8. 

Foster MW, McCullough M. 2001. Plains Apache. In the Plains volume of the Handbook of North American Indians, edited by Raymond J. DeMallie. Smithsonian Institution.

Sharp RR, Foster MW. Spring 2000. Involving study populations in the review of genetic research. The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics. 28:41-51, 3. 

Foster MW, Sharp RR. 2000. Genetic research and culturally specific risks: one size does not fit all. Trends Genet. 16:93-5. 
TOP ^  
The University of Oklahoma Health Sciences Center
OUHSC HOME / SEARCH / FEEDBACK

Endocrinology and Diabetes
1000 N. Lincoln Blvd.; Harold Hamm Oklahoma Diabetes Center Building #2900
Oklahoma City, OK 73104
Phone - (405) 271-5896
FAX - (405) 271-7522


This web site Designed by the Information Design Services a department of the University of Oklahoma Health Sciences Center.

Every effort will be made to update the information contained on these pages as necessary. However, it is the responsibility ofthe user to determine that he or she is relying on the most current version of any particular information. Any questions about the material should be directed to the referenced office or department.